Randomization and supply management is critical to any clinical trial. But traditionally, it has put a painful lag on the overall efficiency of the process. What if you could take back control and get things done in a matter of days, instead of weeks?
Exposure (and Dose) Response Analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group delivers high quality solutions to help our customers get those decisions right.
Your own dedicated project management team
For more than 25 years, Bellwyck has been a true partner in developing smarter solutions for the pharmaceutical industry — from clinical trial to commercialization. Our consulting services start with a dedicated project management team led by a single point of contact throughout your project.
Bringing the patient’s perspective into all phases of development.
Extensive time and energy is often spent designing feasible clinical studies. East's broad range of statistical tools and expert simulations provides an invaluable resource for the rapid construction of trial designs. Illuminating graphs and charts allow for accessible comparison, while a user-friendly interface encourages exploration and experiment.
Expertise in the blinding, packaging and global distribution of investigational products.
TrialScope EngageTM enables clinical trial sponsors to engage with patients and the public via a user-friendly, high impact website to openly share clinical trial information and results, demonstrating leadership in transparency while optimizing trial recruitment and retention.
Cytel has a strong track record in providing CDISC solutions and we are a CDISC Registered Solutions Provider. We have converted more than 150 studies as part of NDA submissions, all of which have been accepted by the FDA. The Clinical Data Interchange Standards Consortium (CDISC) devised the SDTM and ADaM models to standardize data structures for submission of raw and analysis data from clinical trials. These standard formats are increasingly expected by regulatory authorities including the FDA.
Offered as part of our complete supply chain solution, masking or blinding of clinical trial supplies removes investigator and patient bias and limits a potential placebo effect.
Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.
|
|
|
|
|
|
|
|
|